Atria Investments Inc Sells 10,086 Shares of Relx Plc (NYSE:RELX)

Atria Investments Inc trimmed its stake in shares of Relx Plc (NYSE:RELX) by 12.0% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 74,049 shares of the technology company’s stock after selling 10,086 shares during the quarter. Atria Investments Inc’s holdings in Relx were worth $3,514,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also bought and sold shares of the company. Indiana Trust & Investment Management CO bought a new position in shares of Relx in the second quarter worth approximately $52,000. Rothschild Investment LLC bought a new stake in Relx in the 2nd quarter worth $72,000. TFC Financial Management Inc. purchased a new position in shares of Relx in the second quarter valued at about $88,000. Ashton Thomas Private Wealth LLC purchased a new position in shares of Relx in the second quarter valued at about $107,000. Finally, Cullen Frost Bankers Inc. raised its stake in shares of Relx by 119.0% during the second quarter. Cullen Frost Bankers Inc. now owns 2,742 shares of the technology company’s stock valued at $126,000 after acquiring an additional 1,490 shares during the last quarter. 15.02% of the stock is owned by hedge funds and other institutional investors.

Relx Stock Down 1.0 %

Shares of RELX opened at $46.12 on Thursday. Relx Plc has a 1-year low of $36.04 and a 1-year high of $48.91. The firm’s 50-day moving average price is $47.39 and its 200-day moving average price is $45.87.

Analyst Ratings Changes

Several research firms recently issued reports on RELX. StockNews.com began coverage on Relx in a report on Wednesday, October 30th. They set a “hold” rating on the stock. Citigroup upgraded Relx to a “strong-buy” rating in a research report on Tuesday, September 17th.

Relx Company Profile

RELX PLC, together with its subsidiaries, provides information-based analytics and decision tools for professional and business customers in North America, Europe, and internationally. It operates through four segments: Risk; Scientific, Technical & Medical; Legal; and Exhibitions. The Risk segment offers information-based analytics and decision tools that combine public and industry specific content with technology and algorithms to assist clients in evaluating and predicting risk.